Company intelligence / Profile preview
IntelGenx
Saint-Laurent, Quebec, Canadaintelgenx.com ↗
- Ownership
- Public · IGXT
- Employees
- ~75
- Development stage
- Commercial
01
Overview
IntelGenx has sponsored over three dozen clinical studies with several pivotal trials. Its lead pipeline asset Montelukast VersaFilm® has entered Phase II studies targeting neurodegenerative disorders such as Parkinson's disease. The company also has late-stage or approved products in migraine, erectile dysfunction, schizophrenia, chronic pain/opioid dependence, and cannabinoids. Their proprietary oral thin-film platforms offer improved bioavailability and patient compliance compared to traditional formulations.
- Therapeutic areas
- OtherMen's HealthPsychiatryNeurology
- Modalities
- Small moleculePharmaceutical film (oral thin film, transdermal film)CannabinoidsPsychedelic compounds
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
atai Life Sciences – financial support/research collaboration on psychedelic therapiesvarious undisclosed pharmaceutical partners
04
Financials
- Market cap
- $29.7M
- Total revenue
- $174K
- Enterprise value
- $45.4M
Beyond the preview
Go deeper on IntelGenx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IntelGenx.